6-Month Microneedle Array Patch
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Intradermal
-
Intended Duration:
- Short-Acting
- Development Stage: Discovery & Early Development
- Developer(s)/researcher(s): Massachusetts Institute of Technology
Details
- API: Not Yet Determined
- Target: Not Yet Determined
-
Mechanism of Action:
- Not Yet Determined
- Inactive Materials: Not Yet Determined
- Regimen: 1 Patch/6 Months
- MPT: Not Yet Determined
- Promising Attributes: To be established - concept is in early developement
Product Status
Limited Information - Concept Funding Confirmed
History
2024: Massachusetts Institute of Technology receives Gates Foundation grant to develop a 6-month MAP